e-learning
resources
Virtual 2021
07.09.2021
Chronic airway, interstitial, pleural and neoplastic diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hyalyronic acid as predictor of occupational COPD exacerbation
V. Fedotov (Nizhny Novgorod, Russian Federation), B. Tatyana (Nizhny Novgorod, Russian Federation), D. Irina (Nizhny Novgorod, Russian Federation), K. Alexei (Nizhny Novgorod, Russian Federation)
Source:
Virtual Congress 2021 – Chronic airway, interstitial, pleural and neoplastic diseases
Session:
Chronic airway, interstitial, pleural and neoplastic diseases
Session type:
E-poster
Number:
3356
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Fedotov (Nizhny Novgorod, Russian Federation), B. Tatyana (Nizhny Novgorod, Russian Federation), D. Irina (Nizhny Novgorod, Russian Federation), K. Alexei (Nizhny Novgorod, Russian Federation). Hyalyronic acid as predictor of occupational COPD exacerbation. 3356
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Siccine acid effects in patients with exacerbation of severe COPD
Source: Annual Congress 2007 - New insights into the treatment of COPD
Year: 2007
Can asthma severity be a predictor of exacerbation severity?
Source: Eur Respir J 2003; 22: Suppl. 45, 371s
Year: 2003
The occupational contribution to severe exacerbation of asthma
Source: Eur Respir J 2010; 36: 743-750
Year: 2010
Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations?
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
COPD exacerbations and predictors in a general population
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Mortality predictors in COPD exacerbation
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
The occupational contribution to severe exacerbation of current asthma
Source: Annual Congress 2009 - Environmental factors, susceptibility, asthma and COPD
Year: 2009
Can poor compliance be a predictor of asthma exacerbations severity in Ukrainian patients?
Source: Eur Respir J 2006; 28: Suppl. 50, 687s
Year: 2006
Short physical performance battery as a predictor of adverse outcomes following hospitalisation for an acute exacerbation of COPD
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
Serum uric acid as a predictor of mortality and future exacerbations of COPD
Source: Eur Respir J 2014; 43: 43-53
Year: 2004
Exacerbations and professional exposure, predictors for uncontrolled asthma
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009
Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
CRP as predictor as predictor for late treatment failure in hospitalised patients with AECOPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Lack of effect of acute exacerbations on disease progression in ex-smoker COPD patients
Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function
Year: 2010
The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Source: Eur Respir J, 50 (6) 1701820; 10.1183/13993003.01820-2017
Year: 2017
The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Source: Eur Respir J, 50 (6) 1702086; 10.1183/13993003.02086-2017
Year: 2017
The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept